Related Experiment Video
Updated: Sep 11, 2025

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
Gallic, Aconitic, and Crocetin Acids as Potential TNF Modulators: An Integrated Study Combining Molecular Docking,
Adolat Manakbayeva1, Andrey Bogoyavlenskiy1, Timur Kerimov1
1Research and Production Center for Microbiology and Virology, Almaty 050010, Kazakhstan.
Organic acids like gallic, aconitic, and crocetin acids were studied as modulators of Tumor Necrosis Factor (TNF). Gallic and aconitic acids inhibited TNF, while crocetin stimulated it, revealing complex anti-inflammatory potential.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Background:
- Organic acids are vital metabolites influencing human health.
- Tumor Necrosis Factor (TNF) is a key mediator of inflammation and an important therapeutic target.
Purpose of the Study:
- To evaluate organic acids as potential modulators of Tumor Necrosis Factor (TNF).
- To investigate the anti-inflammatory properties of gallic, aconitic, and crocetin acids targeting TNF.
Main Methods:
- In silico molecular docking and molecular dynamics (MD) simulations were employed.
- ADMET profiling assessed pharmacokinetic properties.
- In vivo mouse leukocyte models evaluated TNF gene expression.
Main Results:
- Crocetin exhibited the highest predicted TNF binding affinity, while gallic acid showed the most stable complex.
- ADMET analysis indicated potential pharmacokinetic limitations like low permeability.
- In vivo studies revealed gallic and aconitic acids inhibited TNF, whereas crocetin stimulated it.
Conclusions:
- Organic acids demonstrate complex interactions with TNF, acting as either inhibitors or stimulators.
- Gallic and aconitic acids show potential as TNF inhibitors for anti-inflammatory applications.
- Further research is needed to overcome pharmacokinetic challenges and develop these compounds for TNF-mediated diseases.
More Related Videos
09:08Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF